ZENOTECH Q2 : STANDALONE NET LOSS WIDENS 208% AT ₹2.57 CR (YOY), WIDENS 465% (QOQ). WEAK (ON 1ST LOOK)

Revenue down 40.1% at ₹6.13 Cr (YOY), down 36.1% (QOQ). Ebitda loss at ₹1.61 Cr v profit ₹2.99 Cr (YOY), v profit ₹1.30 Cr (QOQ). Margins -26.2% v 29.2% (YOY), 13.6% (QOQ). Caution: Q2 exceptional item of ₹4.97 L was stated.

Zenotech Laboratories Ltd

Open attachment

← Back to feed